
Keen Eye provides AI-powered tools that improve drug development and diagnostics by analyzing pathology images. It is an AI platform for computational pathology that processes and analyzes pathology images to derive actionable insights. The product targets diagnostic labs, pharmaceutical companies and CROs as a B2B offering, enabling management, analysis and sharing of pathology images. As part of Tribun Health, Keen Eye scales AI-driven pathology workflows and supports digital transformation in cancer diagnostics. It combines computer vision, machine learning and data collaboration to accelerate decision-making in oncology research and clinical trials.

Keen Eye provides AI-powered tools that improve drug development and diagnostics by analyzing pathology images. It is an AI platform for computational pathology that processes and analyzes pathology images to derive actionable insights. The product targets diagnostic labs, pharmaceutical companies and CROs as a B2B offering, enabling management, analysis and sharing of pathology images. As part of Tribun Health, Keen Eye scales AI-driven pathology workflows and supports digital transformation in cancer diagnostics. It combines computer vision, machine learning and data collaboration to accelerate decision-making in oncology research and clinical trials.